Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome

Thrombocytopenia, ascites, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a newly recognized but rare disease, and its treatment has not yet been established. We reported a 50-year-old woman with TAFRO syndrome diagnosed 2 years after the initial symptoms of a fever, fatigue,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurumi, Hanako, Fujigaki, Yoshihide, Yamamoto, Tadashi, Iino, Risa, Taniguchi, Kei, Nagura, Michito, Arai, Shigeyuki, Tamura, Yoshifuru, Ota, Tatsuru, Shibata, Shigeru, Kondo, Fukuo, Kurose, Nozomu, Masaki, Yasufumi, Uchida, Shunya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995702/
https://www.ncbi.nlm.nih.gov/pubmed/29321413
http://dx.doi.org/10.2169/internalmedicine.0116-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995702/
https://www.ncbi.nlm.nih.gov/pubmed/29321413
http://dx.doi.org/10.2169/internalmedicine.0116-17

Ejemplares similares